Kintor Pharmaceutical Limited
KNTPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$155,274 | -$1,068,861 | -$954 | -$516 |
| Dep. & Amort. | $17,627 | $18,976 | $18 | $10 |
| Deferred Tax | $0 | $0 | $155 | $0 |
| Stock-Based Comp. | -$9,112 | $30 | $0 | $0 |
| Change in WC | -$51,136 | -$96,481 | -$197,952 | -$284,588 |
| Other Non-Cash | -$1,185 | $758,755 | $197,772 | $284,043 |
| Operating Cash Flow | -$199,080 | -$387,581 | -$961 | -$1,051 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,538 | -$3 | -$27 | -$76 |
| Net Acquisitions | $0 | $0 | -$18,513 | -$195,534 |
| Inv. Purchases | -$100 | -$137,099 | -$220,702 | -$515,407 |
| Inv. Sales/Matur. | $10,101 | $136,251 | $337,057 | $710,941 |
| Other Inv. Act. | $11,571 | $4,125 | -$97,747 | $168 |
| Investing Cash Flow | $20,034 | $3,274 | $67 | $92 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$115,337 | -$29,400 | $121,600 | -$63,600 |
| Stock Issued | $372 | $755 | $698,763 | $951,972 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4,706 | -$4,818 | -$819,547 | -$887,515 |
| Financing Cash Flow | -$119,671 | -$33,463 | $816 | $857 |
| Forex Effect | $2,109 | -$2,673 | $16 | -$36 |
| Net Chg. in Cash | -$296,608 | -$420,443 | -$62 | -$138 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $444,027 | $864,470 | $926 | $1,065 |
| End Cash | $147,419 | $444,027 | $864 | $926 |
| Free Cash Flow | -$200,760 | -$390,304 | -$989 | -$1,128 |